IRS proteins and diabetic complications

[1]  M. White.  Mechanism of Insulin Action , 2016 .

[2]  G. King,et al.  Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture , 2016, Diabetes.

[3]  Yaling Han,et al.  Association between insulin receptor substrate-1 polymorphisms and high platelet reactivity with clopidogrel therapy in coronary artery disease patients with type 2 diabetes mellitus , 2016, Cardiovascular Diabetology.

[4]  S. Yagihashi,et al.  The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes , 2016, Journal of neurochemistry.

[5]  Á. Valverde,et al.  IRS2 and PTEN are key molecules in controlling insulin sensitivity in podocytes. , 2015, Biochimica et biophysica acta.

[6]  Haobo Li,et al.  Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling. , 2015, Clinical science.

[7]  H. Kume,et al.  Stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in type 2 diabetes with nephropathy. , 2015, Biochemical and biophysical research communications.

[8]  R. Walker,et al.  Sodium Salicylate Reduced Insulin Resistance in the Retina of a Type 2 Diabetic Rat Model , 2015, PloS one.

[9]  J. Steinle,et al.  Serine 307 on insulin receptor substrate 1 is required for SOCS3 and TNF-α signaling in the rMC-1 cell line , 2014, Molecular vision.

[10]  R. Walker,et al.  Pioglitazone Normalizes Insulin Signaling in the Diabetic Rat Retina through Reduction in Tumor Necrosis Factor α and Suppressor of Cytokine Signaling 3* , 2014, The Journal of Biological Chemistry.

[11]  M. Pinazo-Durán,et al.  Retinal neurodegenerative changes in the adult insulin receptor substrate-2 deficient mouse. , 2014, Experimental eye research.

[12]  M. White,et al.  Irs2 and Irs4 synergize in non-LepRb neurons to control energy balance and glucose homeostasis★ , 2013, Molecular metabolism.

[13]  M. White,et al.  Myocardial Loss of IRS1 and IRS2 Causes Heart Failure and Is Controlled by p38α MAPK During Insulin Resistance , 2013, Diabetes.

[14]  Xinmin Zhou,et al.  Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: in vivo and in vitro evidence , 2013, Cardiovascular Diabetology.

[15]  A. Bhanwer,et al.  Polymorphisms in PPARγ (Pro12Ala, C1431T), IRS1 (G972R), IRS2 (G1057D) and Coronary artery disease , 2013, International Journal of Diabetes in Developing Countries.

[16]  C. Taniguchi,et al.  Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes , 2013, Nature Medicine.

[17]  C. Taniguchi,et al.  A liver HIF-2α/IRS2 pathway sensitizes hepatic insulin signaling and is modulated by VEGF inhibition , 2013, Nature Medicine.

[18]  Á. Valverde,et al.  Insulin directly stimulates VEGF-A production in the glomerular podocyte. , 2013, American journal of physiology. Renal physiology.

[19]  M. White,et al.  Insulin receptor substrate‐2 is expressed in kidney epithelium and up‐regulated in diabetic nephropathy , 2013, The FEBS journal.

[20]  Noemi Lois,et al.  Advances in our understanding of diabetic retinopathy. , 2013, Clinical science.

[21]  M. White,et al.  Serine Phosphorylation Sites on IRS2 Activated by Angiotensin II and Protein Kinase C To Induce Selective Insulin Resistance in Endothelial Cells , 2013, Molecular and Cellular Biology.

[22]  Sheng-Xi Wu,et al.  Down-regulation of insulin signaling is involved in painful diabetic neuropathy in type 2 diabetes. , 2013, Pain physician.

[23]  Liang-Miin Tsai,et al.  Gly1057Asp polymorphism of insulin receptor substrate-2 is associated with coronary artery disease in the Taiwanese population , 2012, Journal of Biomedical Science.

[24]  L. Almasy,et al.  The Gly(972)Arg Variant of Human IRS1 Gene Is Associated With Variation in Glomerular Filtration Rate Likely Through Impaired Insulin Receptor Signaling , 2012, Diabetes.

[25]  M. White,et al.  Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 , 2012, Diabetologia.

[26]  E. Feldman,et al.  Insulin-like growth factors in the peripheral nervous system. , 2012, Endocrinology and metabolism clinics of North America.

[27]  J. Steinle,et al.  TNFα and SOCS3 regulate IRS-1 to increase retinal endothelial cell apoptosis. , 2012, Cellular signalling.

[28]  J. Schneider,et al.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. , 2012, The Journal of clinical investigation.

[29]  D. Munoz,et al.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. , 2012, The Journal of clinical investigation.

[30]  P. Pedarzani,et al.  Brain Deletion of Insulin Receptor Substrate 2 Disrupts Hippocampal Synaptic Plasticity and Metaplasticity , 2012, PloS one.

[31]  M. Irwin,et al.  PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. , 2012, Clinical science.

[32]  S. Bahouth,et al.  Silencing of insulin receptor substrate–1 increases cell death in retinal Müller cells , 2012, Molecular vision.

[33]  P. Ghezzi,et al.  Beneficial Effects of PKF275-055, a Novel, Selective, Orally Bioavailable, Long-Acting Dipeptidyl Peptidase IV Inhibitor in Streptozotocin-Induced Diabetic Peripheral Neuropathy , 2012, Journal of Pharmacology and Experimental Therapeutics.

[34]  Eduardo D. Martín,et al.  IRS-2 Deficiency Impairs NMDA Receptor-Dependent Long-term Potentiation , 2011, Cerebral cortex.

[35]  S. Satchell,et al.  Diabetic nephropathy. , 2012, Clinical medicine.

[36]  S. Bahouth,et al.  Role of β-adrenergic receptor regulation of TNF-α and insulin signaling in retinal Muller cells. , 2011, Investigative ophthalmology & visual science.

[37]  S. Houser,et al.  Inhibition of PKC&agr;/&bgr; With Ruboxistaurin Antagonizes Heart Failure in Pigs After Myocardial Infarction Injury , 2011, Circulation research.

[38]  E. Davidson,et al.  Treatment of Streptozotocin-Induced Diabetic Rats with Alogliptin: Effect on Vascular and Neural Complications , 2011, Experimental diabetes research.

[39]  S. Rich,et al.  An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes. , 2011, Kidney international.

[40]  D. Brazil,et al.  Insulin receptor substrate 2 and FoxO3a signalling are involved in E‐cadherin expression and transforming growth factor‐β1‐induced repression in kidney epithelial cells , 2011, The FEBS journal.

[41]  D. Wright,et al.  Insulin Receptor Substrate 2 Expression and Involvement in Neuronal Insulin Resistance in Diabetic Neuropathy , 2011, Experimental diabetes research.

[42]  E. Feldman,et al.  Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. , 2011, Antioxidants & redox signaling.

[43]  R. Ward.  NHS Kidney Care , 2011 .

[44]  C. Kahn,et al.  Insulin signaling to the glomerular podocyte is critical for normal kidney function. , 2010, Cell metabolism.

[45]  Amoolya H. Singh,et al.  A nuclear complex of rictor and insulin receptor substrate-2 is associated with albuminuria in diabetic mice. , 2010, Metabolic syndrome and related disorders.

[46]  C. Kahn,et al.  Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. , 2010, Cell metabolism.

[47]  Rosemary O’Connor,et al.  Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling , 2010, Neurobiology of Aging.

[48]  M. White,et al.  Irs1 serine 307 promotes insulin sensitivity in mice. , 2010, Cell metabolism.

[49]  DCCT and EDIC : The Diabetes Control and Complications Trial and Follow-up Study , 2010 .

[50]  S. Cook,et al.  Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction. , 2010, European heart journal.

[51]  J. H. Park,et al.  Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. , 2009, Archives of medical research.

[52]  H. Krum,et al.  Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy , 2009, Circulation. Heart failure.

[53]  A. Barber,et al.  Retinal ganglion cells in diabetes , 2008, Journal of Physiology.

[54]  G. Glazner,et al.  Distal Degenerative Sensory Neuropathy in a Long-Term Type 2 Diabetes Rat Model , 2008, Diabetes.

[55]  D. Zochodne.  Diabetes mellitus and the peripheral nervous system: Manifestations and mechanisms , 2007, Muscle & nerve.

[56]  J. Tavaré,et al.  Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes , 2007, Diabetes.

[57]  C. Kahn,et al.  Essential Role of Insulin and Insulin-Like Growth Factor 1 Receptor Signaling in Cardiac Development and Function , 2006, Molecular and Cellular Biology.

[58]  G. Striker,et al.  Low insulin-like growth factor binding protein-2 expression is responsible for increased insulin receptor substrate-1 phosphorylation in mesangial cells from mice susceptible to glomerulosclerosis. , 2006, Endocrinology.

[59]  P. Fort,et al.  Diabetes reduces basal retinal insulin receptor signaling: reversal with systemic and local insulin. , 2006, Diabetes.

[60]  Liakishev Aa.  [Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. Results of the DCCT/EDIC study]. , 2006 .

[61]  B. Zinman,et al.  Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.

[62]  J. Tavaré,et al.  The human glomerular podocyte is a novel target for insulin action. , 2005, Diabetes.

[63]  Y. Terauchi,et al.  Roles of insulin receptor substrates in insulin-induced stimulation of renal proximal bicarbonate absorption. , 2005, Journal of the American Society of Nephrology : JASN.

[64]  Jimmy D Bell,et al.  The role of insulin receptor substrate 2 in hypothalamic and beta cell function. , 2005, The Journal of clinical investigation.

[65]  Jens C. Brüning,et al.  The role of insulin receptor signaling in the brain , 2005, Trends in Endocrinology & Metabolism.

[66]  J. Kushner,et al.  Insulin Receptor Substrate 2 Is Essential for Maturation and Survival of Photoreceptor Cells , 2005, The Journal of Neuroscience.

[67]  Jimmy D Bell,et al.  The role of insulin receptor substrate 2 in hypothalamic and beta cell function. , 2005, Journal of Clinical Investigation.

[68]  B. Paulweber,et al.  Lack of association of the Gly972Arg mutation of the insulin receptor substrate‐1 gene with coronary artery disease in the Austrian population , 2004, Journal of internal medicine.

[69]  M. McCarthy,et al.  Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease , 1995, Diabetologia.

[70]  J. Kushner,et al.  Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation , 2003, The Journal of Neuroscience.

[71]  E. Feskens,et al.  Gly972Arg variant in the insulin receptor substrate-1 gene and association with Type 2 diabetes: a meta-analysis of 27 studies , 2003, Diabetologia.

[72]  J. Haigh,et al.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.

[73]  L. Rossetti,et al.  Hypothalamic insulin signaling is required for inhibition of glucose production , 2002, Nature Medicine.

[74]  G. Eknoyan,et al.  On improving outcomes and quality of dialysis care, and more. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[75]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[76]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[77]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[78]  M. White,et al.  Regulation of Insulin/Insulin-like Growth Factor-1 Signaling by Proteasome-mediated Degradation of Insulin Receptor Substrate-2* , 2001, The Journal of Biological Chemistry.

[79]  Michael Karin,et al.  Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ , 2001, Science.

[80]  G. Shulman,et al.  Prevention of fat-induced insulin resistance by salicylate. , 2001, The Journal of clinical investigation.

[81]  R. Klein,et al.  Role of brain insulin receptor in control of body weight and reproduction. , 2006, Science.

[82]  M. White,et al.  [Letters to nature] , 1975, Nature.

[83]  Roger Davis,et al.  The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307 * , 2000, The Journal of Biological Chemistry.

[84]  A. Montali,et al.  A common mutation of the insulin receptor substrate-1 gene is a risk factor for coronary artery disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[85]  M. White,et al.  Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling , 1999, Nature Genetics.

[86]  O. Pedersen,et al.  Insulin receptor substrate-2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians. , 1998, Diabetes.

[87]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[88]  Nadine Bazilinski,et al.  Brenner and Rector's The Kidney , 1997 .

[89]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[90]  M. White,et al.  IRS-1 is a common element in insulin and insulin-like growth factor-I signaling to the phosphatidylinositol 3'-kinase. , 1993, Endocrinology.

[91]  M. Czech.  Insulin action. , 1981, The American journal of medicine.